Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Clinical Study of Contezolid for the Treatment of Bone and Joint Tuberculosis

NCT06811012 is registered in ClinicalTrials.gov with Beijing Chest Hospital as lead sponsor.

NCT NCT06811012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06811012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Clinical Study of Contezolid for the Treatment of Bone and Joint Tuberculosis
Lead sponsor
Beijing Chest Hospital
Phase
Phase 1/2
Overall status
Enrolling by invitation
Start date
January 31, 2024
Completion date
December 31, 2025
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone, joint, tuberculosis